His scientific interests lie mostly in Mycobacterium tuberculosis, Immunology, Tuberculosis, Major histocompatibility complex and Antigen. His Mycobacterium tuberculosis research is multidisciplinary, incorporating perspectives in Inflammation, Interferon, Myeloid, Tuberculin and Vaccination. His work carried out in the field of Immunology brings together such families of science as Pharmacokinetics and Tuberculosis diagnosis.
His research integrates issues of Internal medicine, Disease and Immune system in his study of Tuberculosis. The various areas that W. Henry Boom examines in his Major histocompatibility complex study include Heat shock protein, Molecular biology and Antigen presentation. His biological study deals with issues like Virology, which deal with fields such as Pathogen, Bacterial antigen, Immunogenicity and Immunity.
W. Henry Boom mainly investigates Mycobacterium tuberculosis, Tuberculosis, Immunology, Immune system and Microbiology. His studies in Mycobacterium tuberculosis integrate themes in fields like Genotype, Immunity, Antigen and Isoniazid. He combines subjects such as Internal medicine, Disease, Prospective cohort study and Vaccination with his study of Tuberculosis.
His Immunology study frequently draws connections to other fields, such as Virology. W. Henry Boom has included themes like Phagosome, Phagosome maturation, Mycobacterium bovis and Extracellular in his Microbiology study. His studies deal with areas such as T lymphocyte and Cell biology as well as T cell.
W. Henry Boom spends much of his time researching Mycobacterium tuberculosis, Tuberculosis, Immunology, Internal medicine and Immune system. His Mycobacterium tuberculosis study incorporates themes from Genetics, Phenotype, CD8, Microbiology and Tuberculin. His Microbiology research integrates issues from Phenylbutyrate, Cytokine, T cell, TLR2 and In vivo.
His Tuberculosis study integrates concerns from other disciplines, such as Single-nucleotide polymorphism, Disease, Gene and Vaccination. In general Internal medicine, his work in Cohort, Area under curve and Randomized controlled trial is often linked to Extramural linking many areas of study. His work focuses on many connections between Immune system and other disciplines, such as Flow cytometry, that overlap with his field of interest in Viral load and Clinical trial.
W. Henry Boom mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Internal medicine, Disease and Immunology. His study in the field of Tuberculin also crosses realms of Contact tracing. His work deals with themes such as Epidemiology, Interferon gamma release assay, Latent tuberculosis, Concordance and Asymptomatic, which intersect with Tuberculin.
His Mycobacterium tuberculosis research incorporates themes from Gene, Cohort and Risk of infection. The Internal medicine study combines topics in areas such as Drug resistance and MEDLINE. His study in Disease is interdisciplinary in nature, drawing from both Metabolite, Observational study, Active tb and Transmission.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson.
The Lancet (2016)
Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors
Clifford V. Harding;W. Henry Boom.
Nature Reviews Microbiology (2010)
Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion
Rish K. Pai;Marilyn Convery;Thomas A. Hamilton;W. Henry Boom.
Journal of Immunology (2003)
CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
David H. Canaday;Robert J. Wilkinson;Qing Li;Clifford V. Harding.
Journal of Immunology (2001)
Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function
Nicole D. Pecora;Adam J. Gehring;David H. Canaday;W. Henry Boom.
Journal of Immunology (2006)
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
David Stucki;David Stucki;Daniela Brites;Daniela Brites;Leïla Jeljeli;Mireia Coscolla;Mireia Coscolla.
Nature Genetics (2016)
Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling
Meghan E. Pennini;Rish K. Pai;David C. Schultz;W. Henry Boom.
Journal of Immunology (2006)
Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis
Charles A. Peloquin;David Jamil Hadad;Lucilia Pereira Dutra Molino;Moises Palaci.
Antimicrobial Agents and Chemotherapy (2008)
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.
Gillian F. Black;Bonnie A. Thiel;Martin O. Ota;Shreemanta K. Parida.
Clinical and Vaccine Immunology (2009)
TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.
Michael G. Drage;Nicole D. Pecora;Amy G. Hise;Maria Febbraio.
Cellular Immunology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: